BioCity Biopharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 9

BioCity Biopharma General Information

Description

Developer of innovative pharmaceutical drugs designed to address unmet clinical needs in oncology and nephrology. The company offers differentiated drug discovery programs, clinical-stage development capabilities, and translational research integration, enabling global healthcare systems and patients to access targeted therapeutic options and improved treatment outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 24th Floor, West Building, Huichuang Building
  • Number 581 Jianzhu West Road, Binhu District
  • Wuxi, Jiangsu 214026
  • China
+86 0510
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 24th Floor, West Building, Huichuang Building
  • Number 581 Jianzhu West Road, Binhu District
  • Wuxi, Jiangsu 214026
  • China
+86 0510

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCity Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 27-Apr-2026 Completed Clinical Trials - General
5. Later Stage VC (Series A2) 28-Jan-2026 Completed Clinical Trials - General
4. Secondary Transaction - Private 02-Apr-2025 Completed Clinical Trials - General
3. Later Stage VC (Series A1) 31-Jul-2024 Completed Clinical Trials - General
2. Early Stage VC (Series A) 25-Oct-2020 Completed Clinical Trials - General
1. Early Stage VC 29-Jul-2020 $63.5M Completed Clinical Trials - General
To view BioCity Biopharma’s complete valuation and funding history, request access »

BioCity Biopharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
FirstLight Capital (Beijing) PE/Buyout Minority
Simcere Pharmaceutical Group Corporation Minority
Vivo Capital Venture Capital Minority
Beijing Greatnumbers Asset Management Company Growth/Expansion Minority
Guolian Investment Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

BioCity Biopharma FAQs

  • When was BioCity Biopharma founded?

    BioCity Biopharma was founded in 2017.

  • Where is BioCity Biopharma headquartered?

    BioCity Biopharma is headquartered in Wuxi, China.

  • What industry is BioCity Biopharma in?

    BioCity Biopharma’s primary industry is Drug Discovery.

  • Is BioCity Biopharma a private or public company?

    BioCity Biopharma is a Private company.

  • What is BioCity Biopharma’s current revenue?

    The current revenue for BioCity Biopharma is .

  • Who are BioCity Biopharma’s investors?

    FirstLight Capital (Beijing), Simcere Pharmaceutical Group, Vivo Capital, Beijing Greatnumbers Asset Management Company, and Guolian Investment are 5 of 9 investors who have invested in BioCity Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process